๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-06-04

A Study of AL102 in Patients With Progressing Desmoid Tumors (NCT04871282)

RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors

๐Ÿ”ต Active, Not Recruiting Phase2 / Phase3 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Immunome, Inc.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.

Who can join: Review the eligibility criteria below.

Location: Mayo Clinic โ€” Pheonix, Arizona

Age range: 12 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (53 Sites)

Showing the first 25 of 53 sites.

  • Mayo Clinic โ€” Pheonix, Arizona
  • City of Hope โ€” Duarte, California
  • Sarcoma Oncology Research Center โ€” Santa Monica, California
  • University of California at Los Angeles Hematology/Oncology โ€” Santa Monica, California
  • Stanford University Medical Center โ€” Stanford, California
  • Mayo Clinic โ€” Jacksonville, Florida
  • NorthShore University Health System โ€” Evanston, Illinois
  • Massachusetts General Hospital โ€” Boston, Massachusetts
  • University of Michigan โ€” Ann Arbor, Michigan
  • Jefferson City Medical Group โ€” Jefferson City, Missouri
  • Washington University โ€” St Louis, Missouri
  • Columbia University Irving Medical Center โ€” New York, New York
  • Memorial Sloan Kettering Cancer Center โ€” New York, New York
  • Levine Cancer Institute โ€” Charlotte, North Carolina
  • Cleveland Clinic โ€” Cleveland, Ohio
  • Ohio State University Wexner Medical Center โ€” Columbus, Ohio
  • Oregon Health & Science University โ€” Portland, Oregon
  • Jefferson University Hospital โ€” Philadelphia, Pennsylvania
  • Fox Chase Cancer Center โ€” Philadelphia, Pennsylvania
  • University of Pittsburgh Medical Center, Hillman Cancer Center โ€” Pittsburgh, Pennsylvania
  • UTSW Simmons Cancer Center โ€” Dallas, Texas
  • MD Anderson Cancer Center โ€” Houston, Texas
  • Fred Hutchinson Cancer Center โ€” Seattle, Washington
  • Chris O'Brien Lifehouse โ€” Camperdown, New South Wales
  • Princess Alexandra Hospital โ€” Woolloongabba, Queensland

๐Ÿ“ž Contact the Study Coordinator

Phone: (800) 664-4580

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Desmoid clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—